Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Ampcor, Inc. — Predicate Candidate Screening
15 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
60 daysmedian FDA review time
154 days90th percentile
15clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K922296 | IMFECTIOUS MONONUCLEOSIS IM LIQUID CARD TEST | Ampcor, Inc. | 1992-07-14 | 60 | 0 |
| K922297 | INFECTIOUS MONONUCLEOSIS QIK-DOT IM DRY CARD TEST | Ampcor, Inc. | 1992-07-14 | 60 | 0 |
| K910438 | DIPSTICK SALMONELLA | Ampcor, Inc. | 1991-09-13 | 225 | 0 |
| K893873 | SINGLE AND DUAL BAND DIPSTICK HCG TEST | Ampcor, Inc. | 1989-08-21 | 87 | 0 |
| K890048 | QUIK-DOT TOXOPLASMOSIS | Ampcor, Inc. | 1989-06-09 | 154 | 0 |
| K892146 | C REACTIVE PROTEIN LIQUID | Ampcor, Inc. | 1989-04-14 | 14 | 0 |
| K892119 | QUIK-DOT C REACTIVE PROTEIN | Ampcor, Inc. | 1989-04-14 | 14 | 0 |
| K890025 | QUIK-DOT ANTISTREPTOLYSIN-O | Ampcor, Inc. | 1989-01-31 | 27 | 0 |
| K884750 | GROUP A STREP, BETA-STREP | Ampcor, Inc. | 1988-12-22 | 38 | 0 |
| K880163 | PREGNANCY (HCG) CARD & LIQUID TEST | Ampcor, Inc. | 1988-05-17 | 125 | 0 |
| K880478 | PREGNANCY BETA-HCG CARD & LIQUID TEST | Ampcor, Inc. | 1988-04-28 | 84 | 0 |
| K880165 | TRUST RPR TEST FOR SYPHILIS IN SERUM OR PLASMA | Ampcor, Inc. | 1988-03-30 | 77 | 0 |
| K880477 | RPR TEST FOR SYPHILIS IN SERUM OR PLASMA | Ampcor, Inc. | 1988-03-30 | 55 | 0 |
| K880148 | INFECTIOUS MONONUCLEOSIS (IM) CARD & LIQUID TEST | Ampcor, Inc. | 1988-02-10 | 28 | 0 |
| K880164 | RF CARD TEST & RF LIQUID TEST | Ampcor, Inc. | 1988-02-10 | 28 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda